Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study

STUDY OBJECTIVES: To evaluate efficacy and safety of 3.5-mg zolpidem tartrate sublingual tablets (ZST) on latency to sleep onset after middle-of-the-night (MOTN) awakenings in patients with insomnia characterized by difficulty returning to sleep after MOTN awakenings. DESIGN: Multicenter randomized,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Roth, Thomas, Krystal, Andrew, Steinberg, Frank J., Singh, Nikhilesh N., Moline, Margaret
Médium: Artigo
Jazyk:Inglês
Vydáno: Associated Professional Sleep Societies, LLC 2013
Témata:
Sublingual Low-Dose Zolpidem and Middle-of-the-Night Awakening
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3543068/
https://ncbi.nlm.nih.gov/pubmed/23372266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.2370
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky